Clinical outcome after coronary surgery with heparin-coated extracorporeal circuits for cardiopulmonary bypass

Abstract

In this prospective randomized trial, we studied whether heparin-coated extracorporeal circuits (ECC), known to reduce complement activation, could improve the clinical outcome of 200 patients undergoing coronary artery surgery. Patients have been divided into two groups (heparin-coated ECC and uncoated ECC groups) which were similar in terms of age, gender, left ventricle function, preoperative aspirin use and consequent intraoperative aprotinin use, number of grafts, duration of aortic cross-clamping and cardiopulmonary bypass.

Univariate analysis showed that heparin coating did not reduce significantly postoperative bleeding (640 ± 311 versus 682 ± 342 ml with uncoated ECC) nor the need for transfusion (19% of patients versus 25% with uncoated ECC). Adverse events, including all mortality and morbidity noticed during the five first postoperative days, occurred in 20 patients of the uncoated ECC group and in eight patients of the heparin-coated ECC group (p = 0.013). The most frequent complications were supraventricular arrhythmias that occurred in 13 patients of the uncoated ECC group and in four patients of the heparin-coated ECC group (p = 0.02). Multivariate analysis by stepwise logistic regression showed that only heparin coating of the ECC was shown as a significant predictive factor of adverse events reduction (p = 0.01; odds ratio = 0.34). These data suggest that heparin coating reduced postoperative complications in patients undergoing coronary artery surgery.

Get full access to this article

View all access options for this article.

References

Edmunds LH Blood-surface interactions during cardiopulmonary bypass. J Card Surg 1993; 8: 404-10.

Butler J. , Rocker GM , Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55: 552-59.

Kirklin JK , Westaby S. , Blackstone EH , Kirklin JW , Chenoweth DE , Pacifico AD Complement and damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845-57.

Moore FD , Warner KG , Assousa S. , Valeri CR , Khuri SF The effects of complement activation during cardiopulmonary bypass . Ann Surg 1988; 208: 95-103.

Salama A. , Hugo F. , Heinrich D. et al. Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass. N Eng J Med 1988; 318: 408-14.

Borowiec J. , Thelin S. , Bagge L. , Nillson L. , Venge P. , Hansson HE Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1992; 104: 642-47.

Gu YJ , van Oeveren W. , Akkerman C. , Boonstra PW , Huyzen RJ , Wildevuur ChRH. Heparin coated circuits reduce the inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55: 917-22.

Fosse E. , Moen O. , Johnson E. et al. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1994 ; 58: 472-77.

Norusis MJ SPSS advanced statistics 6.1, 1994; 1-30.

10.

Chenoweth DE , Cooper SW , Hugli TE , Stewart RW , Blackstone EH , Kirklin JW Complement activation during cardiopulmonary bypass. Evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981; 304: 497-503.

11.

Videm V. , Svennevig JL , Fosse E. , Semb G. , Osterud A. , Mollnes TE Reduced complement activation with heparin coated oxygenator and tubings in coronary bypass operations. J Thorac Cardiovasc Surg 1992; 103: 806-13.

12.

Shigenitsu O. , Hadama T. , Takasaki H. et al. Biocompatibility of a heparin-bonded membrane oxygenator (Carmeda MAXIMA) during the first 90 minutes of cardiopulmonary bypass: clinical comparison with the conventional system. Artif Organs 1994; 18: 936-41.

13.

Hatori N. , Yoshiyuki H. , Kusama Y. , Takeshima S. , Segawa D. , Tanaka S. Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass. Artif Organs 1994; 18: 904-10.

14.

Wagner WR , Johnson PC , Thompson KA et al. Heparin-coated cardiopulmonary bypass circuits: hemostatic alterations and postoperative blood loss. Ann Thorac Surg 1994; 58: 734-41.

15.

Matangi MF , Neutze JM , Graham KJ , Hill DG , Kerr AR , Barrat-Boyes BG Arrhythmia prophylaxis after aorto-coronary bypass. The effect of minidose propranolol. J Thorac Cardiovasc Surg 1985 ; 89: 439-43.

16.

Cochrane AD , Siddins M. , Rosenfeldt FL et al. A comparison of amiodarone and digoxin for treatment of supraventricular arrhythmias after cardiac surgery. Eur J Cardiothorac Surg 1994; 8: 194-98.

17.

Leitch JW , Thomson D. , Baird DK , Harris PJ The importance of age as a predictor of atrial fibrillation and flutter after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1990; 100: 338-42.

18.

Patarroyo M. , Makgoba MW Leucocyte adhesion to cells in immune and inflammatory responses. Lancet 1989; 2: 1139-42.

19.

Appleyard RF , Cohn LH Myocardial stunning and reperfusion injury in cardiac surgery. J Card Surg 1993; 8(suppl.): 316-24.

20.

Shandelya Sml , Kuppusamy P. , Weisfeldt ML , Zweier JL Evaluation of the role of polymorphonuclear leukocytes on contractile function in myocardial reperfusion injury. Evidence for plasma-mediated leukocyte activation. Circulation 1993; 87: 536-46.

21.

Kusama Y. , Bernier M. , Hearse DJ Singlet oxygen-induced arrhythmias. Dose- and light-response studies for photoactivation of Rose Bengal in the rat heart. Circulation 1989; 80: 1432-48.

22.

Bochenek A. , Religa Z. , Spyt TJ et al. Protective influence of pretreatment with allopurinol on myocardial function in patients undergoing coronary artery surgery. Eur J Cardiothorac Surg 1990; 4: 538-42.

23.

Kazatchkine MD , Fearon DT , Metcalfe DD , Rosenberg RD , Austen KF Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase . J Clin Invest 1981; 67: 223-28.

24.

Lu H. , Du Buit C. , Soria J. et al. Postoperative hemostasis and fibrinolysis in patients undergoing cardiopulmonary bypass with or without aprotinin therapy. Thromb Haemost 1994; 72: 438-43.

25.

Blauth Cl, Arnold JV, Schulenberg WE, McCartney AC, Taylor KM. Cerebral microembolism during cardiopulmonary bypass. Retinal microvascular studies in vivo with fluorescein angiography. J Thorac Cardiovasc Surg 1988; 95: 668-76.

26.

Rinder CS , Bonan JL , Rinder HM , Mathew J. , Hines R. , Smith BR Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood 1992; 79: 1201-205.

27.

Teoh KH , Weisel RD , Ivanov J. , Teasdale SJ , Glynn Mfx. Platelet dysfunction after coronary artery bypass surgery. In: Friedel N , Hetzer R , Royston D eds. Blood use in cardiac surgery . Darmstadt: Steinkopff and New York: Springer, 1991.

28.

Westaby S. Aprotinin in perspective. Ann Thorac Surg 1993; 55: 1033-41.